For the quarter ended June 2026, Bruker (BRKR Quick QuoteBRKR - Free Report) reported revenue of $838.5 million, up 5.2% over the same period last year. EPS came in at $0.49, compared to $0.32 in the year-ago quarter.

The reported revenue represents a surprise of -2.18% over the Zacks Consensus Estimate of $857.18 million. With the consensus EPS estimate being $0.38, the EPS surprise was +28.95%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Bruker performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Organic revenue growth - Bruker Scientific Instruments (BSI): 2.3% versus 3.9% estimated by two analysts on average.
• Organic revenue growth - Total: 2.8% compared to the 4% average estimate based on two analysts.
• Organic revenue growth - Bruker Energy & Supercon Technologies (BEST): 8.9% versus 6% estimated by two analysts on average.
• Revenue- Eliminations: $-3 million compared to the $-2.42 million average estimate based on two analysts. The reported number represents a change of +42.9% year over year.
• Revenue- Bruker Energy & Supercon Technologies (BEST): $74.2 million versus $72.55 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +11.9% change.

View all Key Company Metrics for Bruker here>>>

Shares of Bruker have returned +4.8% over the past month versus the Zacks S&P 500 composite's +1.7% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.